Literature DB >> 28162822

Doses per vaccine vial container: An understated and underestimated driver of performance that needs more evidence.

Alexis Heaton1, Kirstin Krudwig2, Tina Lorenson3, Craig Burgess2, Andrew Cunningham2, Robert Steinglass2.   

Abstract

The widespread use of multidose vaccine containers in low and middle income countries' immunization programs is assumed to have multiple benefits and efficiencies for health systems, yet the broader impacts on immunization coverage, costs, and safety are not well understood. To document what is known on this topic, how it has been studied, and confirm the gaps in evidence that allow us to assess the complex system interactions, the authors undertook a review of published literature that explored the relationship between doses per container and immunization systems. The relationships examined in this study are organized within a systems framework consisting of operational costs, timely coverage, safety, product costs/wastage, and policy/correct use, with the idea that a change in dose per container affects all of them, and the optimal solution will depend on what is prioritized and used to measure performance. Studies on this topic are limited and largely rely on modeling to assess the relationship between doses per container and other aspects of immunization systems. Very few studies attempt to look at how a change in doses per container affects vaccination coverage rates and other systems components simultaneously. This article summarizes the published knowledge on this topic to date and suggests areas of current and future research to ultimately improve decision making around vaccine doses per container and increase understanding of how this decision relates to other program goals.
Copyright © 2016 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Keywords:  Dose per container; Multidose; Presentation; Vaccine; Vials

Mesh:

Substances:

Year:  2017        PMID: 28162822     DOI: 10.1016/j.vaccine.2016.11.066

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  Differences between coverage of yellow fever vaccine and the first dose of measles-containing vaccine: A desk review of global data sources.

Authors:  Nedghie Adrien; Terri B Hyde; Marta Gacic-Dobo; Joachim Hombach; Akshaya Krishnaswamy; Philipp Lambach
Journal:  Vaccine       Date:  2019-06-29       Impact factor: 3.641

2.  Rational design of heat stable lyophilized rotavirus vaccine formulations.

Authors:  Madhu Madan; Deepa Sikriwal; Gaurav Sharma; Nidhi Shukla; Ashwani Kumar Mandyal; Sachin Kale; Davinder Gill
Journal:  Hum Vaccin Immunother       Date:  2018-07-11       Impact factor: 3.452

3.  The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in Zambia.

Authors:  Kirstin Krudwig; Barbara Knittel; Ali Karim; Natasha Kanagat; Wendy Prosser; Guissimon Phiri; Frances Mwansa; Robert Steinglass
Journal:  Vaccine       Date:  2020-07-21       Impact factor: 3.641

4.  Modeling the economic impact of different vial-opening thresholds for measles-containing vaccines.

Authors:  Patrick T Wedlock; Elizabeth A Mitgang; Assaf P Oron; Brittany L Hagedorn; Jim Leonard; Shawn T Brown; Jennifer Bakal; Sheryl S Siegmund; Bruce Y Lee
Journal:  Vaccine       Date:  2019-03-23       Impact factor: 3.641

5.  Health workers' perceptions and challenges in implementing meningococcal serogroup a conjugate vaccine in the routine childhood immunization schedule in Burkina Faso.

Authors:  Sylvain F Nkwenkeu; Mohamed F Jalloh; Jenny A Walldorf; Robert L Zoma; Felix Tarbangdo; Soukeynatou Fall; Sansan Hien; Roland Combassere; Cesaire Ky; Ludovic Kambou; Alpha Oumar Diallo; Akshaya Krishnaswamy; Flavien H Aké; Cynthia Hatcher; Jaymin C Patel; Isaïe Medah; Ryan T Novak; Terri B Hyde; Heidi M Soeters; Imran Mirza
Journal:  BMC Public Health       Date:  2020-02-19       Impact factor: 3.295

Review 6.  A microneedle patch for measles and rubella vaccination: a game changer for achieving elimination.

Authors:  Mark R Prausnitz; James L Goodson; Paul A Rota; Walter A Orenstein
Journal:  Curr Opin Virol       Date:  2020-07-01       Impact factor: 7.090

7.  Health Care Worker Preferences and Perspectives on Doses per Container for 2 Lyophilized Vaccines in Senegal, Vietnam, and Zambia.

Authors:  Natasha Kanagat; Kirstin Krudwig; Karen A Wilkins; Sydney Kaweme; Guissimon Phiri; Frances D Mwansa; Mercy Mvundura; Joanie Robertson; Debra Kristensen; Abdoulaye Gueye; Sang D Dao; Pham Q Thai; Huyen T Nguyen; Thang C Tran
Journal:  Glob Health Sci Pract       Date:  2020-12-23

8.  Vaccine wastage in The Gambia: a prospective observational study.

Authors:  Effua Usuf; Grant Mackenzie; Lamin Ceesay; Dawda Sowe; Beate Kampmann; Anna Roca
Journal:  BMC Public Health       Date:  2018-07-11       Impact factor: 3.295

9.  Introduction of multi-dose PCV 13 vaccine in Benin: from the decision to vaccinators experience.

Authors:  Daleb Abdoulaye Alfa; Roch A Houngnihin; G Patrick Ilboudo; Naomi Dick; Landry Kaucley; Téné-Alima Essoh
Journal:  BMC Public Health       Date:  2020-08-08       Impact factor: 3.295

10.  Documentation of vaccine wastage in two different geographic contexts under the universal immunization program in India.

Authors:  Manoja Kumar Das; Mangla Sood; Muralidhar Parashuram Tambe; Thakur Dutt Sharma; Malangori Abdul Gani Parande; Jitendra Bhaskar Surwade; Nandakumar Manikrao Salunkhe; Shital Somsing Patil; Bhagwan Pawar; Rajesh Guleri; Chitra Kaushal; Monica Sindhu
Journal:  BMC Public Health       Date:  2020-04-25       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.